Equity Analyst, LightStream Research

Oshadhi Kumarasiri

An equity research analyst with over 7 years of experience in multiple sectors. Previously worked for one of the world's largest asset managers with about USD2.5trn in AUM, covering small and micro-cap companies in the consumer sphere across Europe and developed Asia. Also experienced in covering multiple industries including banking, insurance and asset management, retail, tech, telco and REIT.

Equity Analyst

Kirin: Another Beat Could Turn Consensus from Pessimism into Optimism

Kirin: With Myanmar in the Rear-View Mirror, an Additional 30% Upside Is Quite Possible

Kirin’s Holdco Discount Could Keep Unwinding After The Price Hikes Announcement

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/kirin-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:16977:1" rel="noopener">Kirin Holdings (2503 JP)</a> is eyeing the vitamin game with a proposal to buy Blackmores at AU$95 per share, representing a 23.7% premium over the stock's most recent closing price.</li>
<li>
<a href="https://www.smartkarma.com/entities/blackmores-ltd" target="_blank" data-smartkarma-citation="entities:928:1" rel="noopener">Blackmores Ltd (BKL AU)</a>'s expertise in navigating China's stringent regulations could be the missing piece for Kirin to gain access to the lucrative supplement market in China.</li>
<li>Our main concern is Kirin's history of unsuccessful overseas business acquisitions, particularly outside of its core beer business.</li>
</ul>



Kirin Holdings (2503 JP) is eyeing the vitamin game with a proposal to buy Blackmores at AU$95 per share, representing a 23.7% premium over the stock's most recent closing price.

Blackmores Ltd (BKL AU)'s expertise in navigating China's stringent regulations could be the missing piece for Kirin to gain access to the lucrative supplement market in China.
Our main concern is Kirin's history of unsuccessful overseas business acquisitions, particularly outside of its core beer business.


Kirin's Bid for Blackmores: Leveraging Regulatory Expertise to Enter China's Supplement Market